Analyst Ratings for Oruka Therapeutics (ORKA)
ORKA Rating Summary
ORKA Price Target Summary
- Highest: $75.00 (Piper Sandler)
- Lowest: $40.00 (H.C. Wainwright)
- Average: $55.70
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$55.70 (+68.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/7/2026 | UBS | Michael Yee | New Coverage | Buy (N/A) |
50.00 (N/A) |
26.88 (32.97) |
22.66% | Details |
| 12/18/2025 | Piper Sandler | Yasmeen Rahimi | New Coverage | Overweight (N/A) |
75.00 (N/A) |
28.94 (32.97) |
13.93% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
